U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...
The Trump administration is poised to supercharge America’s appetite for supplements.
Kennedy wants to create "wellness drug rehabilitation farms." But the U.S. tried it before, and it didn't work.